Cardiovascular system response to intravenous administration of physiologic sodium chloride solution in healthy subjects

Introduction. Infusion therapy, despite all its advantages, is not fully understood regarding its impact on the cardiovascular system when large volumes of fluid are used. Objective. To assess the response of the cardiovascular system to massive infusion load in 5 healthy individuals. Materials and Methods. The study included 5 healthy volunteers (2 men and 3 women), with a mean age of 31.6±5.3 years, mean weight of 73.25±15.8 kg, and mean body surface area of 1.83±0.2 m². The study protocol involved the administration of 0.9 % sodium chloride solution through a peripheral catheter for ≈10 hours during the daytime over 2 days, at a volume of 2.2 L/m² body surface area per day. Before the start of the experiment, as well as 48 hours (2 days) and 168 hours (7 days) after the start, all participants underwent measurements of body weight, blood pressure (BP), heart rate (HR), blood tests for NT-proBNP levels, and transthoracic echocardiography. Results. The study found no significant changes in BP, HR, and body weight. A significant increase in NT-proBNP level was noted, rising from 29.3±17.67 ng/ml to 295.4±136.1 ng/ml (p=0.018) after 48 hours of infusion, followed by a decrease (38.0±20.94 ng/ml, p=0.020) and normalization after 7 days. Additionally, after 48 hours, there was an increase in the volume of the left atrium (from 39.2±9.0 ml to 58.2±10.7 ml; p=0.003), basal size of the right ventricle (from 3.44±0.18 cm to 3.66±0.26 cm; p=0.020), and vertical size of the right atrium (from 4.12±0.24 cm to 4.56±0.37 cm; p=0.032), as well as an increase in the amplitude of tricuspid annulus systolic excursion (TAPSE) – from 2.5±0.27 cm to 2.94±0.25 cm; p=0.034) and the E/e’ index (from 3.87±0.52 to 4.83±0.35; p=0.015. Conclusion. Intravenous administration of large volumes of 0.9 %NaCL is associated with an enlargement of the right heart chambers, with enhanced contractility of the right ventricle, increased volume of the left atrium, elevated left ventricular filling pressure, and a marked increase in NT-proBNP. NT-proBNP level should be estimated outside of infusion therapy.

1. Savchenko VG, ed. Autologous hematopoietic stem cell transplantation in hemoblastoses: methodical guide. Moscow; 2020. 96 p. (In Russ.).

2. Clinical guidelines “Follicular lymphoma”. Moscow; 2020. 184 p. (In Russ.).

3. Huang X, Chen W, Ren G, et al. Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis. Clin J Am Soc Nephrol. 2019;14(5):719-727. https://doi.org/10.2215/CJN.10570918.

4. Zhao Y, He R, Oerther S, et al. Cardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients. J Pers Med. 2022;12(12):1797. https://doi.org/10.3390/jpm12111797.

5. Murdych T, Weisdorf DJ. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997. Bone Marrow Transplant. 2001;28(3): 283-287. https://doi.org/10.1038/sj.bmt.1702996.

6. Hertenstein B, Stefanic M, Schmeiser T, et al. Cardiac toxicity of bone marrow transplantation: Predictive value of cardiologic evaluation before transplant. J Clin Oncol. 1994;12(5): 998-1004. https://doi.org/10.1200/JCO.1994.12.5.998.

7. Kupari M, Volin L, Suokas A, et al. Cardiac involvement in bone marrow transplantation: Serial changes in left ventricular size, mass and performance. J Intern Med. 1990;227(3): 259-266. https://doi.org/10.1111/j.1365-2796.1990.tb00132.x.

8. Fujimaki K, Maruta A, Yoshida M, et al. Severe cardiac toxicity in hematological stem cell transplantation: Predictive value of reduced left ventricular ejection fraction. Bone Marrow Transplant. 2001;27(3):307-310. https://doi.org/10.1038/sj.bmt.1702929.

9. Sakata-Yanagimoto M, Kanda Y, Nakagawa M, et al. Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33(10): 1043-1047. https://doi.org/10.1038/sj.bmt.1704718.

10. Lyon AR, Lopez-Fernandez N, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO), and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43(42):4229-4361. https://doi.org/10.1093/eurheartj/ehac244.

11. Snowden JA, Hill GR, Hunt P, et al. Assessment of cardiotoxicity during haemopoietic stem cell transplantation with plasma brain natriuretic peptide. Bone Marrow Transplant. 2000;26(3):309-313. https://doi.org/10.1038/sj.bmt.1702131.

12. Roziakova L, Bojtarova E, Mistrik M, et al. Serial Measurements of Cardiac Biomarkers in Patients after Allogeneic Hematopoietic Stem Cell Transplantation. J Exp Clin Cancer Res. 2012;31(1):13. https://doi.org/10.1186/1756-9966-31-13.

13. Sequeira V, van der Velden J. Historical perspective on heart function: the Frank–Starling Law. Biophys Rev. 2015; 7(4):421-447. https://doi.org/10.1007/s12551-015-0214-3.

14. Schmidt R, Tevs G, eds. Human physiology: in 3 volumes. Vol. 2. Moscow: Mir; 1996. 545 p.

15. Sawada Y, Suda M, Yokoyama H, et al. Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proproteinprocessing endoprotease furin. J Biol Chem. 1997;272(32): 20545-2054. https://doi.org/10.1074/jbc.272.32.20545.

16. Hall C. NT-ProBNP: the mechanism behind the marker. J Card Fail. 2005;11(5 Suppl):S81-83. https://doi.org/10.1016/j.carfail.2005.04.019.

17. Volpe M, Carnovali M, Mastromarino V. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci (Lond). 2016;130(2): 57-77. https://doi.org/10.1042/CS20150469.

18. Kuwahara K. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications. Pharmacol Ther. 2021;227:107863. https://doi.org/10.1016/j.pharmthera.2021.107863.

19. 18. Wijeyaratne CN, Moult PJ. The effect of alpha human atrial natriuretic peptide on plasma volume and vascular permeability in normotensive subjects. J Clin Endocrinol Metab. 1993;76(2):343-346. https://doi.org/10.1210/jcem.76.2.8432776.

20. Ivanova LN, Archibasova VK, Shterental I. Sodium-despositing function of the skin in white rats. Physiological Journal of the USSR named after I. M. Sechenov. 1978;64:358-363. (In Russ.).

21. Selvarajah V, Connolly K, McEniery C, et al. Skin Sodium and Hypertension: a Paradigm Shift? Curr Hypertens Rep. 2018;20(11):94. https://doi.org/10.1007/s11906-018-0892-9.

22. Kumar A, Anel R, Bunnell E, et al. Effect of Large Volume Infusion on Left Ventricular Volumes, Performance and Contractility Parameters in Normal Volunteers. Intensive Care Med. 2004;30(7):1361-1369. https://doi.org/10.1007/s00134-004-2191-y.